NewsFeed
January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab
Jan 29, 2026, 04:58

Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab

Anna Randi, Professor of Cardiovascular Medicine at Imperial College London, shared on LinkedIn:

”Delighted to share the latest episode of the VWF and angiogenesis story from my lab Vascular Section – NHLI, Imperial College London.

Finally, experimental evidence that Angiopoietin2 inhibition could benefit VWD patients with GI bleeding and angiodysplasia.

This was true teamwork: thank you to the excellent members of my team at Imperial, particularly Adela Constantinescu-Bercu and Koval Smith, PhD, and a fantastic network of collaborators (Marco Rasponi, Petrova Lab – Vascular and tumor biology, Suthesh Sivapalaratnam).

A special thanks to the VWD patients who generously donated their blood to advance research.

Thank you to the Medical Research Council, the British Heart Foundation, the Rosetrees trust and the NIHR (National Institute for Health and Care Research) Imperial BRC.

Thank you to Barbara Bianchi Bonomi for the recent generous award, highlighting the relevance of this research to patients with VWD.

A hugely satisfying project with real life impact.”

Read the full article here.

Article: Von Willebrand Factor Deficiency Impairs Angiogenesis via Angiopoietin-2: Relevance for Gut Angiodysplasia

Authors: Adela Constantinescu-Bercu, Koval E Smith, Shuo Yi Wong, Mattia Ballerini, Alessia Nastro, Benjamin G Wiggins, Daniela Pirri, Yucheng Li, Juun Anora Maria Evers, Olga Tsiamita, Matthew Dibble, Charis Pericleous, Koralia E Paschalaki, Graeme M Birdsey, Jeremiah Bernier-Latmani, Tatiana V Petrova, Mike A Laffan, Suthesh Sivapalaratnam, Marco Rasponi, Anna M. Randi

Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab

Stay updated on all scientific advances with Hemostasis Today.